Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats

European Journal of Pharmacology

Volumn 386, Issue 1, 1999, Pages 75-82

  Herling, Andreas W ^a   Burger, Hans Joerg ^a   Schubert, Gerrit ^a   Hemmerle, Horst ^a   Schaefer, Hans Ludwig ^a   Kramer, Werner ^a  

^a SANOFI   (France)

Author keywords

Chlorogenic acid derivative; Glucose production, hepatic; Glucose, blood; Glucose 6 phosphatase; Glycogenesis

Indexed keywords

1 [2 (4 CHLOROPHENYL)CYCLOPROPYLMETHOXY] 3,4 DIHYDROXY 5 (3 IMIDAZO[4,5 B]PYRIDIN 1 YL 3 PHENYLACRYLOYLOXY)CYCLOHEXANE CARBOXYLIC ACID; CARBOHYDRATE; CHLOROGENIC ACID; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; LIPID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; DRUG STRUCTURE; ENZYME INHIBITION; ESTERIFICATION; FATTY ACID BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN SYNTHESIS; HYPOGLYCEMIA; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CHLOROGENIC ACID; CHOLESTEROL; ENZYME INHIBITORS; GLUCONEOGENESIS; GLUCOSE-6-PHOSPHATASE; IMIDAZOLES; INSULIN; KIDNEY; LIPID METABOLISM; LIVER; LIVER GLYCOGEN; MALE; PYRIDINES; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 0033458088     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00748-7     Document Type: Article

References (37)

1. Arion W.J., Wallin B.K., Lange A.J., Ballas L.M. On the involvement of a glucose-6-phosphate transport system in the function of microsomal glucose-6-phosphatase. Mol. Cell Biochem. 6:1975;75-83.
2. Arion W.J., Lange A.J., Walls H.E., Ballas L.M. Evidence for the participation of independent translocation for phosphate and glucose-6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. J. Biol. Chem. 255:1980;10396-10406.
3. Arion W.J., Canfield W.K., Ramos F.C., Schindler P.W., Burger H.J., Hemmerle H., Schubert G., Below P., Herling A.W. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose-6-phosphatase. Arch. Biochem. Biophys. 339:1997;315-322.
4. Arion W.J., Canfield W.K., Callaway E.S., Burger H.J., Hemmerle H., Schubert G., Herling A.W., Oekonomopulos R. Direct evidence for the involvement of two glucose-6-phosphate-binding sites in the glucose-6-phosphatase activity of intact liver microsomes. J. Biol. Chem. 273:1998;6223-6227.
5. Arion W.J., Canfield W.K., Ramos F.C., Su M.L., Burger H.J., Hemmerle H., Schubert G., Below P., Herling A.W. Chlorogenic acid analogue S 3483: a potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems. Arch. Biochem. Biophys. 351:1998;279-285.
6. Ashmore J., Weber G. The role of hepatic glucose-6-phosphatase in the regulation of carbohydrate metabolism. Vitam. Horm. 17:1959;91-132.
7. Bergmeyer H.U. Methoden der Enzymatischen Analyse. 1974;Verlag Chemie, Weinheim.
8. Bligh E., Deyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911.
9. Burchell A. Molecular pathology of glucose-6-phosphatase. FASEB J. 4:1990;2978-2988.
10. Burchell A., Waddell I.D. The molecular basis of the genetic deficiencies of five of the components of the glucose-6-phosphatase system: improved diagnosis. Eur. J. Pediatr. 152(Suppl. 1):1993;S18-S21.
11. Chen Y.T., Burchell A. Glycogen storage disease. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. I:1995;935-965 McGraw-Hill.
12. DeFronzo R.A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
13. Ekberg K., Landau B.R., Wajngot A., Chandramouli V., Efendic S., Brunengraber H., Wahren J. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 48:1999;292-298.
14. Gerin I., Veiga-da-Cunha M., Achouri Y., Collet J.F., van Schaftingen E. Sequence of a putative glucose-6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Letters. 419:1997;235-238.
15. Gitzelmann R., Bosshard N.U. Defective neutrophil and monocyte functions in glycogen storage disease type Ib: a literature review. Eur. J. Pediatr. 152(Suppl. 1):1993;33-38.
16. Greene H.L., Wilson F.A., Hefferan P., Terry A.B., Moran J.R., Slonim A.E., Claus T.H., Burr I.M. ATP depletion, a possible role in the pathogenesis of hyperuricaemia in glycogen storage disease type I. J. Clin. Invest. 62:1978;321-328.
17. Hemmerle H., Burger H.J., Below P., Schubert G., Rippel R., Schindler P.W., Paulus E., Herling A.W. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem. 40:1997;137-145.
18. Herling A.W., Burger H.J., Schwab D., Hemmerle H., Below P., Schubert G. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am. J. Physiol. 274:1998;G1087-G1093. (Gastrointest. Liver Physiol. 37).
19. Jeng C.Y., Sheu W.H.H., Fuh M.T., Chen Y.D.I., Reaven G.M. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes. 43:1994;1440-1444.
20. Jenssen T., Nurjhan N., Consoli A., Gerich J.E. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J. Clin. Invest. 86:1990;489-497.
21. Khan A., Ling Z.C., Herling A.W., Landau B.R., Efendic S. Effects of 3-mercaptopicolinic acid and a derivative of chlorogenic acid (S-3483) on hepatic and islet glucose-6-phosphatase activity. Eur. J. Pharmacol. 349:1998;325-331.
22. Lange A.J., Arion W.J., Beaudet A.L. Type Ib glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system. J. Biol. Chem. 255:1980;8381-8384.
23. Lei K.J., Shelly L.L., Pan C.J., Sidbury J.B., Chou J.Y. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type Ia. Science. 262:1993;580-583.
24. Lei K.J., Pan C.J., Liu J.L., Shelly L.L., Chou J.Y. Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type Ia. J. Biol. Chem. 270:1995;11882-11886.
25. Lei K.J., Chen H., Pan C.J., Ward J.M., Mosinger B., Lee E.J., Westphal H., Mansfield B.C., Chou J.Y. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat. Genet. 13:1996;203-209.
26. Narisawa K., Igarashi Y., Otomo H., Tada K. A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system. Biochem. Biophys. Res. Commun. 83:1978;1360-1364.
27. Nielsen H., Beck O., Nielsen H. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia. 33:1990;603-610.
28. Nordlie R.C. Metabolic regulation by multifunctional glucose-6-phosphatase. Curr. Top. Cell. Regul. 8:1974;33-117.
29. Nordlie R.C. Recent advances in hepatic glucose-6-phosphatase regulation and function. Proc. Soc. Exp. Biol. Med. 203:1993;274-285.
30. Parker J.C., Van Volkenburg M.A., Levy C.B., Martin W.H., Burk S.H., Kwon Y., Giragossian C., Gant T.G., Carpino P.A., McPherson R.K., Vestergaard P., Treadway J.L. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase. Diabetes. 47:1998;1630-1636.
31. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiological Reviews. 75:1997;473-486.
32. Schindler P.W., Below P., Hemmerle H., Burger H.J., Sreedhara Swamy K.H., Arion W.J., Efendic S., Herling A.W. Identification of two new inhibitors of the hepatic glucose-6-phosphatase system. Drug Development Research. 44:1998;34-40.
33. Stumvoll M., Meyer C., Mitrakou A., Nadkarni V., Gerich J.E. Renal glucose production and utilization: new aspects in humans. Diabetologia. 40:1997;749-757.
34. Trinh K.Y., O'Doherty R.M., Anderson P., Lange A.J., Newgard C.B. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J. Biol. Chem. 273:1998;31615-31620.
35. Veiga-da-Cunha M., Gerin I., Chen Y.T., de Barsy T., de Lonlay P., Dionisi-Vici C., Fenske C.D., Lee P.J., Leonard J.V., Maire I., McConkie-Rosell A., Schweitzer S., Vikkula M., Van Schaftingen E. A gene on chromosome 11q23 coding for a putative glucose-6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am. J. Hum. Genet. 63:1998;976-983.
36. Villar-Palasi C., Guinovart J.J. The role of glucose-6-phosphate in the control of glycogen synthase. FASEB J. 11:1997;544-558.
37. Yki-Jarvinen H. The liver as a target for therapy in non-insulin dependent diabetes mellitus. Diabetes, Nutr. Metab. 7:1994;109-119.